Go Pro

Ulta Beauty’s Earnings Beat Was Stronger Than the Stock’s Reaction

Ulta Beauty logo displayed on a wall above the entrance to an Ulta Beauty retail store.

Key Points

  • Ulta Beauty beat earnings and revenue estimates and raised its fiscal 2027 guidance, yet shares initially sold off after the Aug. 27 report.
  • Comparable sales growth of 3.8% marks a sharp deceleration from 6.7% a year earlier, and guidance suggests further slowing in the second half.
  • Analysts remain divided, with Goldman Sachs and DA Davidson raising price targets while Bank of America and Barclays lowered theirs after the report.
  • Five stocks we like better than Ulta Beauty.

Ulta Beauty Today

Ulta Beauty Inc. stock logo
ULTAULTA 90-day performance
Ulta Beauty
$558.15 +12.49 (+2.29%)
As of 12:48 PM Eastern
This is a fair market value price provided by Massive. Learn more.
52-Week Range
$443.60
$714.97
P/E Ratio
20.36
Price Target
$626.59
The retail sector took center stage last week with a bevy of earnings reports, and reactions were mixed, even though most companies beat estimates and raised outlooks. One prime example was Ulta Beauty Inc. NASDAQ: ULTA.

This $23 billion cosmetics colossus reported earnings after the market closed on Aug. 27. Healthy results across the board weren't enough to wow the market, and the stock sold off following the release before paring those losses over the next two sessions.

Even analysts are conflicted over the state of the business, so a deeper dive into the numbers is warranted to figure out where ULTA shares are headed next.

Strong Beat and Guidance Raise Not Enough to Boost Shares

Double beats and raises haven't always been enough to reward companies during the most recent quarter. Many top-line figures in the retail sector were juiced by tariff refunds, which are (hopefully!) a one-time boost that won't be recurring in Q3. Ulta largely escaped the tariff net, which means its Q2 fiscal year 2027 (FY2027) results aren't aided by a one-time cash influx. Earnings per share (EPS) totaled $6.55 in the period, ahead of the estimated $6.22. Revenue also beat estimates, growing 8.9% year over year (YOY), and the company raised its fiscal 2027 sales growth outlook to 6.7%-7.2%. Comp sales also grew 3.8% YOY, and operating income grew more than 10% to $379.6 million.

So why the tepid response to a genuinely good quarter? The first factor standing out is gross margin, which dipped from 39.2% to 39.1%. But that largely reflects last year's Space NK acquisition, a U.K. retailer with structurally lower economics. Operating margin actually improved 10 basis points (bps) YOY, so the margin story starts on flimsy ground. The real concern is growth, which the company's own projections show will slow in the coming months.

Acquisitions and New Store Openings Shroud Growth Deceleration

Ulta Beauty MarketRank™ Stock Analysis

Overall MarketRank™
91st Percentile
Analyst Rating
Moderate Buy
Upside/Downside
14.8% Upside
Short Interest Level
Healthy
Dividend Strength
N/A
News Sentiment
1.49mentions of Ulta Beauty in the last 14 days
Insider Trading
Selling Shares
Proj. Earnings Growth
11.38%
See Full Analysis
Comp sales grew faster than expected in Q2 FY2027, but 3.8% growth is a stark drop from 6.7% a year ago. The full-year guide (3.2%-3.7%) also implies a further slowdown in the second half of the year to approximately 2% -3%, which equates to single-digit growth over a full fiscal year. Management is telling the market not to expect 2025 growth rates to persist into the second half of 2026 or 2027, hence the stock now trades at 18 times forward earnings. ULTA shares traded as high as 25 times earnings as recently as January, so this valuation stepdown feels more like a proper re-rating than unfair punishment.

Additionally, it's worth reiterating what comp sales strip out: new stores and acquisitions. The gap between net sales outlook and comp sales expectations is supplied by the Space NK acquisition and 31 new store openings, the latter of which laps in the next reporting period. Investors are not buying the 8.9% headline revenue growth figure in the future, nor the 13.3% EPS growth. The 2024 buyback authorization program expires at the end of this year, and any further repurchase agreements will need board approval. Ulta will have bought back $3 billion worth of shares at the culmination of this program, and a lack of future buybacks will likely suppress the 13.3% EPS growth back toward the 10.1% operating income growth figure. If comps and buybacks continue to decline (and the company doesn't make another acquisition), the market could re-rate the stock even lower.

Analysts and the Chart Show Conflicting Momentum Far From Settled

Beauty is in the eye of the beholder, which is why multiple stock analysis firms can view the same report and reach different conclusions. The day after the report, Goldman Sachs and DA Davidson raised their price targets, while Bank of America and Barclays Group lowered theirs. Even experts disagree, and the stock's price action reflects buyers' and sellers' conflicting motivations.

Ulta Beauty stock holds a tight trading range below its 200-day moving average as RSI momentum trends higher.

ULTA shares are still down nearly 10% year-to-date (YTD), although the stock has recovered about half of its losses over the last three months. A Death Cross in early May put bulls on the defensive, but the Relative Strength Index (RSI) began trending up from Oversold levels shortly thereafter. The RSI re-entered bullish territory as the share price overtook the 50-day moving average, a resistance level not surpassed since early March.

But now comes the tough part. The next earnings catalyst is still three months away, and the stock is now stuck between resistance at the 200-day moving average and support at the 50-day moving average. A break above the 200-day would be a strong signal that the uptrend is resuming, but if the RSI dips back under 50, it could mean another long period of range-bound trading ahead of fiscal Q3 results.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Ulta Beauty Right Now?

Before you consider Ulta Beauty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ulta Beauty wasn't on the list.

While Ulta Beauty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Dan Schmidt
About The Author

Dan Schmidt

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Ulta Beauty (ULTA)
4.5679 of 5 stars
$557.292.1%N/A20.29Moderate Buy$626.59
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines